Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Stopping the depression medication improved the woman's eyebrow hair loss, and a treatment for a skin condition caused by mites was effective.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Ashwagandha may help promote hair growth.

Treating both bipolar disorder and hair-related BDD with psychiatric medications improved the patient's symptoms.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

JAK inhibitors may reduce depression in people with alopecia areata.

Bacopa monniera promotes hair growth, enhances memory, and helps with inflammation and stomach issues.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Human hair is a significant sample for various tests in clinical, nutritional, archaeological, and forensic studies.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Alopecia areata is a hair loss condition that may be linked to stress and genetics, often requires psychological support, and has no set treatment.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Some drugs may cause hair loss in women.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Certain medications like antipsychotics and some antidepressants increase the risk of falls in older patients.

Shell ginger contains kavalactones that promote hair growth and have anti-cancer, anti-inflammatory, and anti-obesity effects.

SAD patients show different brain activity patterns, which might help identify the disorder.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.